Cannabis Boom: Innovations Rise, Health Gains Lag Behind
The clinical cannabis evidence gap highlights the disconnect between rapid product innovations and limited health gains. Despite industry growth, clinical trials supporting therapeutic efficacy remain scarce. Clinicians must navigate this gap carefully…
Challenges in Cannabis Testing as Virginia Retail Market Approaches
2026 cannabis testing challenges persist as Virginia's retail market nears launch. Current THC detection methods remain unreliable for assessing impairment. Clinicians must understand these limitations to ensure patient safety.
LIVE: News Patrol (10AM) | ANC (6 April 2026) – YouTube
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic Media LiteracyEvidence-Based…
Regular Cannabinoid Use and Inflammatory Biomarkers: A Meta-Analysis
This cannabinoids and inflammation systematic review examines inflammatory biomarkers in regular cannabinoid users. The meta-analysis synthesizes data from over 54,000 participants. Findings highlight complex associations between cannabinoid use and…
Cannabis and Anxiety Relief in Real-World Patients: A 45-Day Longitudinal Analysis
A 45-day longitudinal study tracked cannabis-use days anxiety relief in 416 medical cannabis patients. Cannabis-use days showed larger same-day reductions in anxiety compared to non-cannabis days. This real-world data highlights patient-reported benefits…
